- Recent Funding
- Investors
- Liverpool City Region Combined Authority
Liverpool City Region Combined Authority portfolio
Liverpool City Region Combined Authority has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Inovus Medical's $20M funding round in September 2026, alongside NPIF – Mercia Equity Finance, Unorthodox Ventures and PXN Ventures. That company is in Health and bio.
What Liverpool City Region Combined Authority invests in
- Health and bio · 1 · 100%
How Liverpool City Region Combined Authority invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| round | 1 100% | $20M |
Liverpool City Region Combined Authority portfolio companies
IInovus Medical$20Mround · Sep 2026
| Company | Round with Liverpool City Region Combined Authority | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
round · $20M | $20M | Sep 29, 2026 round |
Most frequent co-investors
PPXN Ventures1 shared round · last Sep 29, 2026
UUnorthodox Ventures1 shared round · last Sep 29, 2026
NNPIF – Mercia Equity Finance1 shared round · last Sep 29, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Liverpool City Region Combined Authority. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Liverpool City Region Combined Authority, which is a subset of its real portfolio. API: /api/v1/investors/liverpool-city-region-combined-authority (get a free API key). More: the most active VC firms and new venture capital funds.